logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/08/2025
Circle's revenue in the second quarter was 658 million U.S. dollars, a year-on-year increase of 53%; net loss was 482 million U.S. dollars.
Latest
2 m ago
Dongyao Pharmaceutical-B(01875.HK) Leads the Industry in CDMO Technology in the First Half of the Year, Achieving Breakthrough in Global Layout of Core Products.
3 m ago
Most of the rare earth concept stocks in the US stock market have strengthened, with USA Rare Earth up more than 19%, American Resources up more than 6%, and MP Materials up more than 2%.
4 m ago
British and eurozone bond prices continue to fall, with the yield on 30-year British bonds rising by 9 basis points to 5.48%.
5 m ago
Bayer and Kinnow Bio have reached a $1.3 billion cooperation agreement.
5 m ago
Kanghong Pharmaceutical Company: Unlawful individuals are impersonating the company's name to engage in fraud and other activities.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.